John P. Hamill, SVP & CFO at WINDTREE THERAPEUTICS INC /DE/ (WINT), bought 3,000 shares at $0.37 ($1K) on 2022-07-26, disclosed to the SEC on 2022-07-26.
Open-market purchase of $1k WINT by SVP & CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| APRE | BUY | 2024-10-16 | $123 | — | Filing → |
| APRE | BUY | 2024-10-15 | $1K | — | Filing → |
| APRE | BUY | 2024-03-14 | $7K | — | Filing → |